Skip to content

Small breast cancer trial finds no clear fatigue advantage for eurythmy

Early closure left a limited comparison of mindful movement therapy and slow-paced exercise for women with metastatic breast cancer.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

This trial did not establish that eurythmy reduced cancer-related fatigue more than slow-paced exercise. Fatigue improved in both groups in tentative analyses, but recruitment stopped early and few participants completed treatment. The absence of a detected difference does not prove the approaches are equivalent, and the results remain too uncertain for firm comparative conclusions.

Keep in mind

The trial stopped because enrollment was insufficient. Only a small group finished, and the open-label design and tentative analyses restrict what this abstract can establish.

THE RESULT, WITH CONTEXT

What researchers found

No detected between-group difference

Cancer-related fatigue

From baseline to the end of the 20-week program, both eurythmy and slow-paced exercise groups improved in tentative analyses; no between-group effect size was reported.

Oncologist, 2025 · Original source ↓

The primary comparison

The key question was whether fatigue changed differently between the movement approaches. Both groups followed matching schedules for session frequency and duration, and the primary outcome was fatigue change from treatment start to finish.

Secondary findings stay tentative

Secondary analyses reported higher quality of life in the eurythmy group and a difference in how pain interference changed. These tentative signals do not resolve the primary fatigue question or overcome the enrollment problem.

CHECK THE ORIGINAL

The original publication

Randomized controlled trial on eurythmy therapy versus slow-paced physical exercises for the treatment of fatigue in metastatic breast cancer patients.

Timm E, Berlowitz I, Wolf U
Oncologist · 2025

PubMed ID
41123285
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.